Presolicitation
Japanese Encephalitis Vaccine (JEV)
SPE2DP-24-R-0002
Defense Logistics Agency, DLA Troop Support. Biological Product (except Diagnostic) Manufacturing.
Awarded
$0.00 obligated so far on USAspending
Description
As published on SAM.gov.
Solicitation:
SPE2DP-24-R-0002 Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV)
NSN:
6505-01-607-7018 Description: The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 4 dated 30 January 2020, which is attached to this notice. The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1), only one responsible source. The Government intends to use Part 12 for this acquisition – per FAR 10.002(d)(2).
The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of a one-year base term. The minimum quantity is 200,060 EA. The estimated quantity is 208,320 EA. The maximum quantity is 300,300 EA.
Inspection/Acceptance at Destination FOB Destination Delivery Destination:
DODAAC: SV3100 DLA Distribution Susquehanna U Avenue, Bldg. 89, Door 6 New Cumberland, PA 17070 Attn: Jim Earp Production Lead Time is 120 days after issuance date of the delivery order (DD1155). All responsible sources may submit a proposal and shall be considered by the Agency. The successful contractor shall have FDA approval to sell JEV before award decision.
IMPORTANT NOTICES Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/.
Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Valneva Usa, Inc.
- UEI
- NT38AFWQNKM7
- CAGE
- 43FM1
- Vendor location
- Bethesda, MD
- Contract
- SPE2DP25D0002
- Obligated
- $0.00, potential $49,297,248
- Actions
- 3 between January 29, 2025 and August 11, 2025
- Competition
- Full and Open Competition, 2 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 4610117748!japanese Encephalit
- Match
- solicitation number SPE2DP24R0002 equals the FPDS solicitation identifier; same awarding office SPE2DP (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 12, 2024
Presolicitation, originally sources sought
Due August 28, 2024 at 11:59 PM EDT. SAM.gov, notice 977e8d101a7e4e8f9e3ee9f36cf36bc0
Points of contact
- Jessica De La Hozjessica.delahoz@dla.mil2157377137
Also open from this buyer
- 2027 Southern Hemisphere Influenza VaccinePresolicitationNAICS 325414SPE2DP26R0002Closes in 13 daysSep 30